Announcements Trials
Browse Landscape

Phase

Phase 1 48Phase 1/2 29Phase 2 8Phase NA 3Phase EARLY_PHASE1 1Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 24Head & Neck 3Gynecologic 2Thoracic 1Dermatologic 1

Conditions

Melanoma 55Skin Neoplasms 16Carcinoma, Basal Cell 11Breast Neoplasms 10Sarcoma 8Lymphoma, T-Cell, Cutaneous 6Lung Neoplasms 5Keratosis, Actinic 5Carcinoma, Renal Cell 5Squamous Cell Carcinoma of Head and Neck 4Lymphoma 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Uveal Melanoma 3Sezary Syndrome 3Mycosis Fungoides 3Kidney Neoplasms 3Intraocular Lymphoma 3Hodgkin Disease 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Hepatocellular 3Breast Neoplasms, Male 3Waldenstrom Macroglobulinemia 2Small Cell Lung Carcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Triple Negative Breast Neoplasms × Dermatologic × Clear all
NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Radiopharm Theranostics, Ltd

Phase EARLY_PHASE1 Recruiting
30 enrolled
BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡